Nontypeable Haemophilus influenzae (NTHi)

Nontypeable Haemophilus influenzae is a small, acapsulate Gram-negative coccobacillus that colonizes the human upper respiratory tract. Unlike encapsulated strains (types a–f), nontypeable strains lack a polysaccharide capsule and therefore cannot be classified by serotype. They are major causes of non-invasive diseases such as acute otitis media in children and bronchitis in adults but can also cause invasive infections including pneumonia, meningitis, and bacteremia[1][4][8]. NTHi forms biofilms that contribute to chronicity and antibiotic resistance in diseases like otitis media and chronic obstructive pulmonary disease exacerbations[3][5]. The organism exhibits significant strain-to-strain heterogeneity in outer membrane molecules which complicates vaccine development. It evades host defenses through mechanisms such as IgA1 protease production, complement inhibitor binding proteins, biofilm formation with extracellular DNA release via type IV secretion-like systems, and resistance to antimicrobial peptides[1][3]. Antibiotic resistance is an increasing problem for NTHi due to beta-lactamase production or mutations affecting penicillin-binding proteins; thus treatment often requires broader-spectrum antibiotics like amoxicillin/clavulanic acid or cephalosporins[7]. No effective vaccine exists for nontypeable strains despite ongoing research targeting surface-exposed adhesins involved in haem/iron acquisition pathways[2]. **Note:** This entry describes an entire bacterial species rather than a specific molecular target such as a receptor or enzyme. Therefore, *is_target* should be **false**, since "Nontypeable Haemophilus influenzae" refers to the whole organism rather than a discrete druggable molecule. *is_incorrect* should be **true**, because this does not correspond to the typical definition of a therapeutic target used in drug discovery databases—where targets are usually individual proteins or molecular complexes within pathogens rather than the pathogen itself. If you require information on specific *molecular targets* within *Nontypeable Haemophilus influenzae*, such as its outer membrane protein D (Protein D), haem acquisition systems (like PE), IgA1 proteases, etc., please specify so structured data can be provided at the appropriate level of granularity for drug discovery purposes.

Other names

Non-typeable Haemophilus influenzaeNon-typeable H. influenzaeNTHi

Antibiotics inhibit cell wall synthesis or other essential bacterial processes